Fenbendazole Price, Suppliers, and Access - in Australia

Summary and core details

Active substance: Fenbendazole.

What it is: Fenbendazole belongs to the benzimidazole family of anthelmintics. It acts on parasite microtubules by binding to beta-tubulin, disrupting glucose uptake and cellular structure, which leads to death of susceptible worms and some protozoal species.

How it is supplied in Australia: Veterinary formulations include oral granules (common sachet sizes such as 222 mg and 444 mg), 10 percent oral suspensions for companion animals, and larger liquid products for livestock use.

Regulatory note: Fenbendazole is not an approved medicine for human treatment by the Therapeutic Goods Administration located in Australia. Research into possible anticancer properties exists but any human use would be unapproved. Examine the section on Australian law for approvals and access at Australian law paired with the process of approvals and access.

Open to section quick navigation medication dosage guidancea thorough review adverse reactionscompare the results with another way forward products, or view the price planning guide.

Relevance to veterinary care

Fenbendazole is widely used as a broad-spectrum dewormer across many animal species. Common markers include infestation by:

• roundworms such as Toxocara and Toxascaris
• hookworms including Ancylostoma and Uncinaria
• whipworms (Trichuris species)
• certain tapeworms, notably Taenia species (less effective for Dipylidium)
• some protozoa, for example Giardia in selected regimens
• strongyles and Strongyloides depending on host species and dosing

Notes on experimental human applications: Laboratory and preclinical studies have explored microtubule-targeted effects in cancer biology, but these do not constitute approved markers throughout Australia. For lawful access pathways conjoined with the regulatory position, read Approvals and access under the Australian legal system.

Dose administration and instructions protocol guidelines

Dosing must be chosen according to the animal species, weight, product strength besides the parasite being targeted. A typical dog regimen for common intestinal nematodes is about 50 mg per kg once daily for three days. Veterinarians may recommend other schedules, repeat courses, or adjustments based on diagnostic testing and reinfestation risk.

Strong points currently available and formats include 222 mg and 444 mg sachets of granules and 10 percent suspensions. Accurate weight-based dosing is important; follow the product label approved by the Australian Pesticides and Veterinary Medicines Authority or your veterinarian's instructions. For information about keeping products, see external storage expands available space for files. instructions.

Human use: Any consideration of fenbendazole for people would be an unapproved use in Australia and should only occur within lawful medical frameworks. See Australian law governing how approvals and access are granted for options such as Special Access Scheme procedures and legal constraints.

Unwanted reactions with safety reminders

Most animals tolerate fenbendazole with few problems. When adverse reactions happen they are usually mild but may include:

• gastrointestinal disturbances such as reduced appetite, vomiting or diarrhea
• temporary alterations in blood cell counts after prolonged or very high dosing
• raised liver enzyme tests in some cases; rare reports of liver injury exist

If an animal develops jaundice, very dark urine, pale stools, marked lethargy, or persistent vomiting or diarrhea, stop treatment and seek veterinary assessment. Related guidance on severe exposure and monitoring is available under recommendations for responding to an opioid overdose and guardrails and tips for monitoring and logging.

Safety measures and monitoring recommendations

• Liver concerns: Use caution in animals with known hepatic disease. For extended or high-dose regimens, baseline and follow-up liver tests may be advised.
• Pregnancy and breeding: Safety can vary by species and product. Refer to a specialist a veterinarian before treating pregnant or breeding animals.
• Confirm infection before treatment: Diagnostic methods such as fecal flotation, antigen tests or PCR help identify the parasite and guide treatment choice and timing.
• Combination therapy: Using fenbendazole with other anthelmintics or supplements should be done under veterinary direction to avoid social contact and responses influence perceptions and decisions. or additive toxicity. See people relating to one anothers at scale reveal systemic patterns. and drug considerations.

Pharmacotherapy the exchange that happens when people meets between people can shape outcomes. and clinical considerations

Detailed collaborative interaction studies are limited for many species. Practical points to discuss with your veterinarian include:

• co-administration with other drugs that are metabolised by the liver may increase hepatic workload; monitor liver parameters if required
• inform your vet about any supplements, herbal remedies or over-the-counter products, since these may affect drug handling or animal tolerance
• combined anthelmintic regimens can be useful to broaden spectrum or overcome resistance, but such protocols should be designed by a clinician

If you are unsure about a specific combination, consult a veterinarian and assess both protective guidelines and lingering effects.

Cautions against use due to medical reasons and Safety Risk General warnings

• known hypersensitivity to fenbendazole or any product excipients
• significant liver disease where monitoring and logging is not possible or risks are judged to outweigh benefits
• use in pregnancy when product- and species-specific safety data are inadequate

If any of these apply, seek veterinary advice before giving fenbendazole. When there are urgent safety concerns, see the official mentorship. recommendations to handle overdosed on medication incidents.

Dose not taken advisory and steps

If a scheduled dose is missed, administer it as soon as you remember unless the next dose is due soon. Do not double doses to make up for the missed one. If in doubt, contact your veterinarian to confirm how to proceed with the dosing schedule.

How to respond to an consuming an overdose

Single accidental fatal overdoses are usually not life threatening for most species, but repeated or very large fatal overdoses can cause bone marrow suppression and blood count changes. If you suspect an fatal overdose, seek veterinary care immediately and bring the product container or label so the attending clinician can verify the concentration and quantity involved.

Internal modular storage systems allow easy reconfiguration. protocol

• store at below 25 C and keep products away from excessive heat, moisture and direct sunlight
• do not freeze unless the product label specifically allows freezing
• keep containers tightly closed and keep medicines out of reach of children and animals

Retain the original packaging for batch numbers and expiry dates. For dosing information revisit administration and guidelines for determining the dose.

The Australian law governing approvals and access

• human approval: fenbendazole is not approved by the Therapeutic Goods Administration for use in people in Australia; public promotion of unapproved human tokens is restricted
• veterinary regulation: veterinary fenbendazole products are regulated by the Australian Pesticides and Veterinary Medicines Authority and must be used according to the registered label unless directed otherwise by a veterinarian
• scheduling and access: many human anthelmintics such as albendazole, ivermectin and praziquantel are prescription-only (Schedule 4). Some small pack formulations of mebendazole or pyrantel for threadworm are available from pharmacies (Schedule 2)
• unapproved access pathways: clinicians may request unapproved medicines via TGA pathways such as the Special Access Scheme or Authorised Prescriber arrangements. Personal importation is limited and subject to conditions; such imports remain unapproved and may be intercepted at the border
• self-administering veterinary medicines: using animal products on people is not recommended and can be unsafe and noncompliant with regulators; consult a medical practitioner for human treatments and a veterinarian for animals

Check current guidance from your state or territory health authority and the TGA or APVMA websites for the latest rules. For human-approved treatment options, see analogous medicines and an additional choice drugs.

Substitute therapies and comparable drugs

Choice of agent depends on the diagnosed parasite, host species, local resistance patterns and safety requirements to weigh. Popular substitutes used in Australia include:

• pyrantel embonate: effective for threadworms and in many veterinary combination products; commonly supplied as an over-the-counter pharmacy medicine for humans
• mebendazole: a human benzimidazole used for intestinal nematodes with small pack availability for threadworm
• albendazole: a broad-spectrum benzimidazole for tissue-invasive helminths; prescription-only
• praziquantel: highly effective against tapeworms; available as both human and veterinary formulations
• ivermectin: a macrocyclic lactone used for many nematodes; human use usually requires a prescription
• milbemycin oxime (often combined with praziquantel): used in routine parasite prevention for dogs and cats
• febantel: a prodrug in veterinary combinations, expanding spectrum when combined with pyrantel or praziquantel
• oxfendazole: another benzimidazole used in animals, with species-specific dosing
• metronidazole: an antiprotozoal sometimes used for giardiasis under veterinary guidance

Discuss diagnostic results and local product availability with a veterinarian to select the most appropriate treatment. Peek at the price and value guide for indicative costs and Australia access compliance rules for legal context.

Price guide in AUD

Current retail prices vary by brand, formulation, pack size and seller. The following are approximate retail ranges in Australian dollars and are indicative only:

• Fenbendazole granule sachet packs for dogs (example 3-sachet packs 222 mg or 444 mg): around AUD 10 to 30
• Fenbendazole 10 percent oral suspension for companion animals (example 100 ml): roughly AUD 20 to 45
• Livestock liquid formulations (1 L or larger): often in the range AUD 120 to 250 or more depending on concentration
• Mebendazole human threadworm packs: approximately AUD 10 to 20
• Pyrantel embonate human preparations from pharmacies: typically AUD 8 to 18
• Albendazole (human prescription courses): commonly AUD 30 to 70 depending on brand and pack size
• Ivermectin or praziquantel human prescription courses: often AUD 20 to 60, variable by formulation and subsidies

Pharmacy and veterinary clinic prices differ and PBS listing or prescription charges may affect human medicine costs. Confirm up-to-date prices with Australian pharmacies, veterinary practices or reputable online retailers.

Reporting of adverse events and disposal

• report suspected adverse events in animals to your veterinarian conjoined with the product sponsor; the APVMA accepts reports for veterinary products
• if humans are exposed or harmed by a veterinary product, seek medical attention and consider notifying the TGA if a human medicine is implicated
• disposal: do not pour unused or leftover suspensions into drains; return expired or unwanted veterinary medicines to your veterinarian or use a participating pharmacy safe disposal program where available

For safety during ongoing therapy see oversight and safety first: steps to take best practices and long term effects and safety reminders.

Central reminders and rapid links

• this page is informational and does not replace professional advice from a veterinarian or a medical practitioner
• confirm the exact parasite diagnosis and a weight-based dosing plan with a qualified professional before starting treatment
• for fast navigation return to the the essentials at a glance or transition to information pertaining to the law at The framework of Australian law: approvals and access and to dosing at dose and administration information